The 7th Operationalize: Expanded Access Programs Summit returns at a pivotal moment as Expanded Access Programs evolve beyond a purely operational function to become a strategic component of patient access, evidence generation, post-trial planning, and commercial readiness. As organizations expand access into new global markets and face growing expectations around real-world data, patient continuity, and reimbursement transitions, EAP leaders are under increasing pressure to build scalable, sustainable, and patient-centric programs.
- Strengthening global post-trial access strategies to ensure long-term patient continuity while navigating regional regulatory and reimbursement complexities
- Leveraging real-world data generated through Expanded Access to support clinical development, regulatory strategy, and future market access decisions
- Navigating complex global access pathways across established and emerging markets while adapting programs to diverse healthcare systems and local requirements
- Building sustainable and scalable EAP models through improved governance, regulatory intelligence, operational frameworks, and digital innovation
What to Expect:
- 150+ Pharma, Biotech & Patient Access Leaders
- 20+ Expert Speakers from Takeda, Regeneron, Alexion, Alnylam, Merck, Sanofi & More
- Interactive Regional Networking & Peer Benchmarking Sessions
- Dedicated Workshops Covering EAP Strategy, Operations & Post-Trial Access
- Live Problem-Solving Discussions & Access Insights Poster Exchanges
Bringing together leaders responsible for medical affairs, patient access, clinical operations, regulatory strategy, and late-phase development, this industry-led summit offers a unique opportunity to benchmark approaches, share practical lessons, and build meaningful connections with peers navigating the same challenges.
By attending, you’ll be in the room with professionals from Takeda, Regeneron, Alexion, Alnylam, Merck, Sanofi, Sarepta Therapeutics, Jazz Pharmaceuticals, Beam Therapeutics, Amylyx and more.
Across three days of workshops, case studies, panel discussions, and networking, gain practical insights into global access strategy, post-trial access, real-world data generation, reimbursement transitions, and regulatory intelligence while helping shape the future of Expanded Access Programs.
Discover the Full 2027 Agenda Here: https://ter.li/5w26qieq